Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 3/20 | 0.49 |
| ▸ | CNR1 | P21554 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4096417 | 0.94 | EPHX2 (0.60) | EPHX2MEN1KMT2AFAAHCNR1 | |
| SCHEMBL2701073 | 0.94 | EPHX2 (0.60) | EPHX2MEN1KMT2AFAAHCNR1 | |
| SCHEMBL2701074 | 0.94 | EPHX2 (0.60) | EPHX2MEN1KMT2AFAAHCNR1 | |
| SCHEMBL4886542 | 0.94 | EPHX2 (0.60) | EPHX2MEN1KMT2AFAAHCNR1 | |
| SCHEMBL4320018 | 0.94 | EPHX2 (0.60) | EPHX2MEN1KMT2AFAAHCNR1 | |
| SCHEMBL5028879 | 0.94 | EPHX2 (0.52) | EPHX2MEN1KMT2AFAAHCNR1 | |
| SCHEMBL2952168 | 0.89 | MEN1 (0.68) | MEN1KMT2ACNR1ALDH1A1HPGD | |
| SCHEMBL14984044 | 0.89 | FAAH (0.48) | EPHX2MEN1KMT2AFAAHALDH1A1 | |
| SCHEMBL6940505 | 0.87 | ALDH1A1 (0.50) | EPHX2MEN1KMT2AFAAHALDH1A1 | |
| SCHEMBL23521334 | 0.86 | ALDH1A1 (0.54) | MEN1KMT2AFAAHALDH1A1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10322994-B2 | Fatty amides and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2019-06-18 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-9573884-B2 | Imidazoline amides and derivitives from natural oil metathesis | STEPAN COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| EP-2632256-B1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-02-01 | — | — | EP | disclosed |
| US-20150376118-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2015-12-31 | — | — | US | disclosed |
| US-9175245-B2 | Fatty amides and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012061094-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SGMS1, DEGS1, DGAT2 | EPHX2 1002/4885MEN1 1517/4885KMT2A 1148/4885 |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | EPHX2 878/4885MEN1 1612/4885KMT2A 1128/4885 |
| US-20150376118-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | EPHX2 878/4885MEN1 1612/4885KMT2A 1128/4885 |
| US-10322994-B2 | Fatty amides and derivatives from natural oil metathesis | DEGS1, SGMS1, DGAT2 | EPHX2 878/4885MEN1 1612/4885KMT2A 1128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.